VAMP2 and early-onset autosomal dominant Alzheimer disease: However, we did not detect the significant reduction of VAMP2 mRNA in our small-scale human samples [t(10) = 0.6, P = 0.52, t-test, 6 Alzheimer’s disease and 6 controls].